Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on the NYSE and NASDAQ
Here is a table of 5 cannabis stocks that are developing cannabis compound medicines.
| 5 Cannabis Pharma Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Abbvie | ABBV | |
| Arena Pharmaceuticals | ARNA | |
| Cara Therapeutics | CARA | |
| GW Pharmaceuticals | GWPH | |
| Zynerba Pharmaceuticals | ZYNE | |
| Price charts from Alpha Vantage as of most recent close. | ||
Portfolio Values
To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.All 5 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,000.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
The current value of a $10,000 investment is $16,875. The percent return is 68.75%. The annualized return is 11.03%.
See Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on OTC Markets.
Related Portfolios
Database with Comments of Marijuana (Cannabis) Stocks (A-Z)
Portfolio of Marijuana (Cannabis) Growers Stocks Traded on the NYSE and NASDAQ
Portfolio of Marijuana (Cannabis) Stocks
Portfolio of Marijuana (Cannabis) Stocks Traded on OTC Markets